Sign in

CIK 0002130606 · Non-accelerated filer<br>Emerging growth company

Obsidian Therapeutics, Inc.

Sign in to watch
Ticker
OBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
421977778
Phone
(781) 806-6245
Business address
1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
Former names
Gazelle Parent, Inc.
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. EFFECT Other Notice of Effectiveness
  3. S-1 Offering Registration Statement
  4. 8-K/A Event Exhibits
  5. 10-Q Report Quarterly Report
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 35 filings